C. Abasq
Impact in
- Pathology and Forensic Medicine top 10%
- Autoimmune Bullous Skin Diseases
- Dermatology top 5%
- Dermatology and Skin Diseases
Papers in
-
- Dermatology and Skin Diseases 6
-
- Psoriasis: Treatment and Pathogenesis 2
- Co-authors
- P. Joly (5 shared papers)L. Misery (9 shared papers)Philippe Musette (2 shared papers)E. Brenaut (3 shared papers)V. Grassi (1 shared paper)François Tron (1 shared paper)Hugo Mouquet (1 shared paper)Danièle Gilbert (1 shared paper)
In The Last Decade
C. Abasq
23 papers receiving 363 citations
Peers
Comparison fields: 5 of 55
- Pathology and Forensic Medicine 168
- Dermatology 76
- Genetics 67
- Rheumatology 91
- Immunology and Allergy 27
Countries citing papers authored by C. Abasq
This map shows the geographic impact of C. Abasq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Abasq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Abasq more than expected).
Fields of papers citing papers by C. Abasq
This network shows the impact of papers produced by C. Abasq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Abasq. The network helps show where C. Abasq may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Abasq, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 106 | |
| 2 | 2014 | 91 | |
| 3 | 2017 | 37 | |
| 4 | 2020 | 37 | |
| 5 | 2021 | 23 | |
| 6 | 2014 | 17 | |
| 7 | 2021 | 15 | |
| 8 | 2019 | 6 | |
| 9 | 2015 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 4 | |
| 12 | 2017 | 4 | |
| 13 | 2014 | 3 | |
| 14 | 2016 | 3 | |
| 15 | 2023 | 3 | |
| 16 | 2025 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2018 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2022 | 1 |
About C. Abasq
C. Abasq is a scholar working on Dermatology, Immunology, Surgery, Pathology and Forensic Medicine and Cell Biology, having authored 29 papers that have together received 372 indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (6 papers), Autoimmune Bullous Skin Diseases (4 papers), Vascular Malformations and Hemangiomas (4 papers), Allergic Rhinitis and Sensitization (3 papers), Asthma and respiratory diseases (3 papers), Skin and Cellular Biology Research (2 papers), Plant Pathogens and Fungal Diseases (2 papers) and Psoriasis: Treatment and Pathogenesis (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (168 citations), Dermatology (76 citations), Genetics (67 citations), Rheumatology (91 citations) and Immunology and Allergy (27 citations). C. Abasq has collaborated with scholars based in France, Réunion and Germany. Frequent co-authors include P. Joly, L. Misery, Philippe Musette, E. Brenaut, V. Grassi, François Tron, Hugo Mouquet, Danièle Gilbert, Fabien Zagnoli and Pascale Marcorelles. Their work appears in journals such as British Journal of Dermatology, Journal of the American Academy of Dermatology, Annales de Dermatologie et de Vénéréologie, Journal of the European Academy of Dermatology and Venereology and Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.